NewGenIvf Group Limited (NASDAQ:NIVF) Sees Significant Decrease in Short Interest

NewGenIvf Group Limited (NASDAQ:NIVF) was the recipient of a significant decrease in short interest in July. As of July 31st, there was short interest totaling 8,932 shares, a decrease of 86.7% from the July 15th total of 67,374 shares. Currently, 0.2% of the shares of the stock are short sold. Based on an average daily volume of 245,249 shares, the short-interest ratio is presently 0.0 days.

Insider Activity at NewGenIvf Group

In related news, major shareholder Financial Lp Hrt sold 28,439 shares of NewGenIvf Group stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $2.40, for a total transaction of $68,253.60. Following the transaction, the insider owned 18,187 shares in the company, valued at approximately $43,648.80. The trade was a 60.99% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 31.80% of the stock is owned by insiders.

NewGenIvf Group Trading Up 2.4%

NIVF stock traded up $0.01 during midday trading on Wednesday, reaching $0.53. 56,512 shares of the company traded hands, compared to its average volume of 876,751. NewGenIvf Group has a 52-week low of $0.52 and a 52-week high of $513.00. The business has a 50 day moving average of $1.42 and a 200-day moving average of $5.32. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16.

NewGenIvf Group (NASDAQ:NIVF) last released its earnings results on Tuesday, March 31st. The company reported ($861.72) earnings per share (EPS) for the quarter. The firm had revenue of $1.42 million for the quarter. On average, sell-side analysts forecast that NewGenIvf Group will post 14.22 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on NIVF. Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Friday, July 24th. Wall Street Zen upgraded shares of NewGenIvf Group to a “hold” rating in a research report on Saturday, July 4th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of “Sell”.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.